Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Clinical Update

Angiotensin-II–receptor blockers and nephropathy in patients with type 2 diabetes

Donald Farquhar
CMAJ November 13, 2001 165 (10) 1379;
Donald Farquhar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 165 no. 10 1379
PubMed 
11760990
History 
  • Published online November 13, 2001.
Copyright & Usage 
© 2001

Author Information

  1. Donald Farquhar

Statistics from Altmetric.com

Usage statistics: April 2002 to September 2023

AbstractFullPdf
Apr 20020207
Mar 200302513
Apr 20030376
May 200302718
Jun 20030317
Jul 20030343
Aug 20030222
Sep 20030387
Oct 200303110
Nov 200303510
Dec 20030433
Jan 20040637
Feb 200403411
Mar 20040358
Apr 20040355
May 200406211
Jun 20041894
Jul 200406310
Aug 20040527
Sep 20040385
Oct 20041593
Nov 20040192
Dec 20040192
Jan 20050202
Feb 20050235
Mar 20052277
Apr 20050165
May 20050158
Jun 20050155
Jul 20050104
Aug 20050159
Sep 20050136
Oct 20050188
Nov 20050126
Dec 20050140
Jan 20090511
Feb 2009072
Mar 2009053
Apr 2009036
May 20090113
Jun 2009073
Jul 2009013
Aug 20090122
Sep 2009072
Oct 20090143
Nov 200901610
Dec 2009012
Jan 2010043
Feb 2010010
Mar 2010065
Apr 2010072
May 2010063
Jun 2010042
Jul 2010011
Aug 2010001
Sep 2010072
Oct 2010063
Nov 2010061
Dec 2010052
Jan 2011042
Feb 2011042
Mar 2011080
Apr 2011042
May 2011052
Jun 2011061
Jul 2011002
Aug 2011002
Sep 2011042
Oct 2011003
Nov 2011034
Dec 2011031
Jan 2012031
Feb 20120174
Mar 2012093
Apr 20120129
May 2012095
Jun 2012083
Jul 2012094
Aug 2012017
Sep 2012044
Oct 2012061
Nov 20120134
Dec 2012091
Jan 20130224
Feb 2013083
Mar 2013021
Apr 2013065
May 20130112
Jun 2013011
Jul 2013002
Aug 2013040
Sep 2013021
Oct 2013050
Nov 2013040
Dec 2013030
Feb 2014001
Apr 2014010
May 2014010
Aug 2014051
Sep 2014060
Oct 2014081
Nov 2014040
Dec 2014010
Feb 2015030
Mar 2015040
May 2015040
Jul 2015020
Aug 2015040
Sep 2015020
Oct 2015031
Nov 2015030
Dec 2015021
Jan 2016091
Feb 2016063
Mar 2016007
May 2016010
Jun 2016021
Jul 2016033
Aug 2016011
Sep 2016041
Oct 20160311
Nov 20160414
Dec 2016029
Jan 2017027
Feb 2017002
Mar 2017030
Apr 2017006
May 2017008
Jun 20170010
Jul 2017007
Aug 2017005
Sep 2017029
Oct 20170013
Nov 2017044
Dec 2017074
Jan 2018072
Feb 2018051
Mar 2018075
Apr 20180287
May 20180183
Jun 20180242
Jul 2018098
Aug 2018008
Sep 2018010
Oct 2018041
Nov 2018040
Dec 20180100
Jan 2019061
Feb 2019031
Mar 2019031
Apr 2019032
May 2019020
Jul 2019011
Aug 2019011
Sep 2019020
Oct 2019051
Nov 2019055
Dec 2019014
Jan 2020023
Feb 2020013
Mar 2020041
Apr 2020026
May 2020031
Jun 2020040
Jul 2020030
Aug 2020020
Sep 2020031
Oct 2020003
Nov 2020057
Dec 2020032
Jan 2021081
Feb 2021001
Mar 2021081
Apr 2021040
May 20210120
Jun 2021063
Jul 2021032
Aug 2021012
Sep 2021030
Oct 2021033
Nov 2021063
Dec 2021011
Jan 2022032
Feb 2022082
Mar 2022060
Apr 2022026
May 2022041
Jun 2022077
Jul 2022048
Aug 2022043
Sep 2022041
Oct 2022071
Nov 20220816
Dec 2022041
Jan 2023083
Feb 2023035
Mar 2023070
Apr 2023011
May 2023033
Jun 2023063
Jul 2023038
Aug 2023043
Sep 2023020
PreviousNext
Back to top

In this issue

CMAJ
Vol. 165, Issue 10
13 Nov 2001
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Angiotensin-II–receptor blockers and nephropathy in patients with type 2 diabetes
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Angiotensin-II–receptor blockers and nephropathy in patients with type 2 diabetes
Donald Farquhar
CMAJ Nov 2001, 165 (10) 1379;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Angiotensin-II–receptor blockers and nephropathy in patients with type 2 diabetes
Donald Farquhar
CMAJ Nov 2001, 165 (10) 1379;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Early treatment of acute hepatitis C infection may lead to cure
  • Colorectal cancer screening: you can't be positive about a negative result
Show more Clinical Update

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire